Cardiovascular Outcomes in Hypertension-Treated Patients With Peripheral Artery Disease: The VALUE Trial

医学 缬沙坦 内科学 心肌梗塞 危险系数 心脏病学 血压 氨氯地平 冲程(发动机) 心力衰竭 不利影响 比例危险模型 冠状动脉疾病 置信区间 机械工程 工程类
作者
Mislav Vrsalović,Sondre Heimark,Camilla Lund Søraas,Maria H. Mehlum,Sverre E. Kjeldsen,Giuseppe Mancia,Stevo Julius,Michael A. Weber
出处
期刊:Hypertension [Lippincott Williams & Wilkins]
卷期号:81 (7): 1628-1636 被引量:2
标识
DOI:10.1161/hypertensionaha.124.22832
摘要

BACKGROUND: Systolic blood pressure (BP) is a key predictor of cardiovascular events, but patients with peripheral artery disease (PAD) are rarely included in hypertension trials. The VALUE trial (Valsartan Antihypertensive Long-Term Use Evaluation) investigated the long-term effects of valsartan- or amlodipine-based treatments on cardiovascular outcomes in patients with hypertension with a high cardiovascular risk. The aim of this subanalysis was to clarify the relationship between achieved BP on treatment and cardiovascular outcomes in patients with hypertension with PAD. METHODS: Patients were followed for 4 to 6 years, and BP was measured regularly. The primary end point was time to the first major adverse cardiovascular event, including myocardial infarction, stroke, cardiovascular death, and heart failure requiring hospitalization. Statistical analyses were performed using Cox regression, adjusting for various baseline covariates. RESULTS: Of the 13 803 participants, 1898 (13.8%) had PAD. During a median follow-up of 4.5 years, patients with PAD had a 23% increased risk of major adverse cardiovascular events compared with patients without PAD. Patients with an achieved systolic BP <130 mm Hg and 130 to 139 mm Hg, compared with those with systolic BP ≥140 mm Hg, were associated with a decreased risk of a major adverse cardiovascular event (hazard ratio, 0.65 [95% CI, 0.43–0.97]; P =0.037; 0.85 [95% CI, 0.74–0.97]; P =0.016, respectively). Additionally, systolic BP <130 mm Hg was associated with a decreased risk of cardiovascular death (hazard ratio, 0.33 [95% CI, 0.12–0.92]; P =0.034). The incidence of the primary outcome did not differ between antihypertensive treatment regimens ( P =0.365). CONCLUSIONS: Our results indicate that more intensive BP control is associated with a reduction in cardiovascular morbidity and mortality in patients with hypertensive PAD.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ava的应助被Hedy采纳,获得10
刚刚
研友_VZG7GZ的应助被哈电话采纳,获得10
刚刚
xucc发布了新的文献求助10
1秒前
NexusExplorer的应助被0717采纳,获得10
1秒前
1秒前
华仔的应助被初景采纳,获得10
1秒前
yyd完成签到,获得积分10
1秒前
Luobing发布了新的文献求助10
1秒前
cdf发布了新的文献求助10
1秒前
2秒前
默默发布了新的文献求助10
2秒前
2秒前
酷波er的应助被DongLiang采纳,获得10
3秒前
3秒前
温柔樱桃发布了新的文献求助10
3秒前
3秒前
3秒前
双枪普朗克完成签到,获得积分10
3秒前
3秒前
Lucas的应助被张琳采纳,获得10
4秒前
彭佳乐完成签到,获得积分10
4秒前
Seasons发布了新的文献求助10
4秒前
5秒前
谎言不会伤人完成签到,获得积分10
5秒前
DPF做梦的乌龟完成签到,获得积分20
5秒前
小松弟完成签到,获得积分10
5秒前
5秒前
ding的应助被飘逸雨竹采纳,获得10
5秒前
5秒前
5秒前
MMM关闭了MMM的文献求助
6秒前
宋秋莲发布了新的文献求助10
6秒前
十一发布了新的文献求助10
6秒前
6秒前
Owen的应助被Shaelyn_Cheung采纳,获得10
6秒前
NexusExplorer的应助被feiyu采纳,获得10
6秒前
6秒前
8秒前
111发布了新的文献求助10
8秒前
狂炫砂糖柑完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Markov Decision Processes and Reinforcement Learning 700
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8170166
求助须知:如何正确求助?哪些是违规求助? 9563213
关于积分的说明 21768986
捐赠科研通 7761665
什么是DOI,文献DOI怎么找? 3430630
关于科研通互助平台的介绍 2554458
邀请新用户注册赠送积分活动 2475393